Early skeletal and biochemical alterations in pediatric chronic kidney disease.
about
Interventions for metabolic bone disease in children with chronic kidney diseaseBone disease in pediatric chronic kidney diseaseRelationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing ParathyroidectomyFracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study.Evaluating bone quality in patients with chronic kidney disease.Changes in bone structure and the muscle-bone unit in children with chronic kidney disease.Role of TGF-β in a mouse model of high turnover renal osteodystrophy.CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.FGF23 protein expression in coronary arteries is associated with impaired kidney function.Chronic kidney disease: mineral and bone disorder in children.Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.Primary osteoblast-like cells from patients with end-stage kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivo.Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients.Longitudinal FGF23 and Klotho axis characterization in children treated with chronic peritoneal dialysis.Altered Osteocyte-Specific Protein Expression in Bone after Childhood Solid Organ Transplantation.FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysisThe demise of calcium-based phosphate binders-is this appropriate for children?The consequences of chronic kidney disease on bone metabolism and growth in children.Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease.Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in NeonatesUric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function.Disordered FGF23 and mineral metabolism in children with CKDOptimization of Bone Health in Children before and after Renal Transplantation: Current Perspectives and Future Directions.Correction of lower limb deformities in children with renal osteodystrophy by guided growth technique.Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children.Intestinal phosphate transport: a therapeutic target in chronic kidney disease and beyond?The role of bone in CKD-mediated mineral and vascular disease.Defective skeletal mineralization in pediatric CKD.The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder.Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway.Evaluation of fracture risk in chronic kidney disease.Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder.Variability in measures of mineral metabolism in children on hemodialysis: impact on clinical decision-making.Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.The bone kidney axis.Pediatric solid organ transplantation and osteoporosis: a descriptive study on bone histomorphometric findings.Fractures and Osteomalacia in a Patient Treated With Frequent Home Hemodialysis.Cardiovascular risks in chronic kidney disease pediatric patients.
P2860
Q24187788-4BF9B781-08CF-4ADC-9736-73A133F99759Q26864102-4D0712E4-04F5-4F81-A0FB-8A076082EBDAQ28546638-1F72C360-86E9-43B1-A54B-486E8520DBF0Q30703135-8AFCF925-96ED-4E6D-8BEF-D001089514B0Q33602332-DE113A0B-A791-461F-9738-13C5E9D41603Q33696234-A60863D6-43B5-405A-8FE6-37BF517DFF29Q33827652-18E782C7-C268-428D-AA0A-018D2383DBCCQ33974636-E134A64C-A4E6-4FBE-91E0-7133B2A480DFQ33985430-349ABC71-09F5-4C08-9539-00E7455E4119Q34402661-2DB5B9F8-DF60-4147-B97A-DAB0782223E5Q35058295-9AFD63C3-A148-4E88-82BF-AA7060F25B19Q35132542-2601ED06-C985-4887-B20B-46C0D4626FACQ35182281-88F66981-20BF-4114-864A-20F465928058Q35232118-457FE528-F7C1-455F-9F3A-0BE84474B531Q35782011-8B879997-A8D2-4765-BE48-8EE02E960BCAQ35949319-B5A43351-0D0C-401D-841E-11178C8002F7Q36214854-0E2583C7-575D-473C-8790-0D3F1249A318Q36318290-F54EDFFA-599E-4E07-94EB-48BEB4A54C53Q36817218-4688A4AE-BB8F-4033-8FE6-4697B2192ADFQ36935548-636C8A37-454B-44C1-9CD4-F5C81EF4404CQ37221997-7BF3F564-328C-463B-A141-182B4805700AQ37553097-195CD3CA-4D8C-48AA-B5C2-6E39260A11A5Q37598894-2CF7FC3B-32CC-4BD9-84EB-375406B99541Q37739293-47F9F600-ADE2-4724-80F4-28DDF1C0CCC6Q38034690-FEAC2E56-6A0E-40E2-846D-8F0B581BCAA9Q38053246-33A64ECB-587D-46CD-BF2C-75C8572871E4Q38079128-074F4F9D-93B8-40D7-B589-F02BB925788AQ38185277-B66D0D3D-4BA5-4C5E-B6B4-C6FF7A6CACEAQ38244314-53BBD483-DFA1-4093-A04D-7000AC187EC4Q38339007-05264CE7-4B86-490F-8499-E2FCBFA48BBDQ38584122-FF124EB4-5F45-4639-B2E9-A4FCC173A412Q38605457-B8DCE4EB-1D9E-4A55-8586-171C38A7AF7FQ39225909-CBB7141E-0241-4ABD-98AA-F64628E37795Q39271483-C0F3E50A-F97F-489F-BC3B-99FE3B7BA438Q40138771-FD740715-A6F3-4576-BFAC-83DF5F38949CQ41146384-F5A82E5A-B12B-404D-B0DD-4D7B95B4984EQ41438552-94D7E0E3-48EB-429E-A9AC-CC660735305BQ43471541-797A7779-0B0A-41AE-BFF4-0454A1440069Q46275115-B67B3E8C-9578-40BA-926B-5812D40A00E9Q47112805-813E1544-D006-4A76-8415-0AD3A97A24EC
P2860
Early skeletal and biochemical alterations in pediatric chronic kidney disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Early skeletal and biochemical alterations in pediatric chronic kidney disease.
@ast
Early skeletal and biochemical alterations in pediatric chronic kidney disease.
@en
type
label
Early skeletal and biochemical alterations in pediatric chronic kidney disease.
@ast
Early skeletal and biochemical alterations in pediatric chronic kidney disease.
@en
prefLabel
Early skeletal and biochemical alterations in pediatric chronic kidney disease.
@ast
Early skeletal and biochemical alterations in pediatric chronic kidney disease.
@en
P2093
P2860
P356
P1476
Early skeletal and biochemical alterations in pediatric chronic kidney disease.
@en
P2093
Barbara Gales
Chi-Hong Tseng
Harald Jüppner
Isidro B Salusky
Joshua J Zaritsky
Katherine Wesseling-Perry
Renata C Pereira
Shobha Sahney
P2860
P304
P356
10.2215/CJN.05940611
P577
2011-11-03T00:00:00Z